NCT07564427

Brief Summary

This study aims to verify whether high-intensity pulsed electromagnetic fields (HI-PEMF) can be effectively applied to postoperative total hip arthroplasty patients. Using pain and function as the primary assessment indicators, the study explores the effects of HI-PEMF on postoperative total hip arthroplasty to confirm its effectiveness in relieving pain and improving daily living functions. Simultaneously, it combines physical therapy with exercise training to simulate a clinical environment, comprehensively understanding the feasibility of future clinical applications of magnetic field therapy. It is hoped that by exploring the potential benefits of magnetic field intervention in improving the postoperative condition of these high-needs patients, new clinical evidence can be provided for postoperative management.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
15mo left

Started Apr 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
Apr 2026Jul 2027

First Submitted

Initial submission to the registry

April 27, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

April 28, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 4, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2027

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2027

Last Updated

May 4, 2026

Status Verified

April 1, 2026

Enrollment Period

1 year

First QC Date

April 27, 2026

Last Update Submit

April 27, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • WOMAC

    measuring THR patient pain and function

    1-month

Study Arms (2)

Arm 1:HI-PEMF+exercise

EXPERIMENTAL

HI-PEMF+exercise

Device: High-Intensity Pulsed Electromagnetic Field, HI-PEMF+ post operative exerciseOther: Post Operative exercise

Arm 2 :exercise

ACTIVE COMPARATOR
Other: Post Operative exercise

Interventions

High-Intensity Pulsed Electromagnetic Field (HI-PEMF) is a non-invasive, contactless technology delivering strong magnetic pulses (up to 3 T or more) to biological tissue. It serves as a superior alternative to traditional electropermeabilization by altering cell membrane permeability. And post operative exercise.

Arm 1:HI-PEMF+exercise

Post operative program exercise for THR

Arm 1:HI-PEMF+exerciseArm 2 :exercise

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A. Age 18 years or older.
  • B. Patients who have undergone primary unilateral total hip arthroplasty due to hip osteoarthritis.
  • C. Patients who, after postoperative evaluation by their surgeon, are advised to bear full weight within their tolerance.

You may not qualify if:

  • A. Patients who have not undergone primary hip arthroplasty.
  • B. Patients who are advised by their doctor to maintain non-weight-bearing or partial weight-bearing on the affected or unaffected side.
  • C. History of neurological deficits (e.g., sensory abnormalities, stroke, spinal cord injury, Parkinson's disease, multiple sclerosis).
  • D. Mini-Mental State Examination (MMSE) \< 24 (mild cognitive impairment).
  • E. Berger's Balance Scale (BBS) \< 40 (higher risk of falls).
  • F. Sensory abnormalities.
  • G. Before or after this exercise training, if pain in other areas (e.g., degenerative pain in the knee or spine) prevents movement, or if the hip joint still experiences pain on a Visual Analogue Scale (VAS) score of 4 or higher even after taking pain medication.
  • H. Known malignancy.
  • I. Schizophrenia, bipolar disorder, or substance addiction (e.g., alcohol, drug).
  • J. Pregnant woman.
  • K. Individuals with implanted stents, pacemakers, or those requiring treatment for arrhythmia.
  • L. Wearing a hearing aid.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Tsang-Ming (倉銘) Chang (張)

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 27, 2026

First Posted

May 4, 2026

Study Start

April 28, 2026

Primary Completion (Estimated)

April 30, 2027

Study Completion (Estimated)

July 30, 2027

Last Updated

May 4, 2026

Record last verified: 2026-04